Effect of propofol in different doses on the measurement of analgesics

Effects of different concentrations of oxycodone on propofol effective dose during painless gastroscopy

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000029928

Enrollment

Unknown

Registered

2020-02-16

Start date

2020-02-17

Completion date

Unknown

Last updated

2020-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Interventions

Group A and Group B:Different doses of oxycodone

Eligibility

Sex/Gender

Female

Age

18 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. Female patients with radical mastectomy after neoadjuvant chemotherapy; 2. Aged 18-55 years old; 3. BMI 20-25 kg/m2; 4. Asai or level II.

Exclusion criteria

Exclusion criteria: 1. History of systemic diseases; 2. Be able to communicate normally; 3. Long term use history of analgesics; 4. Uncontrolled history of hypertension, arrhythmia and heart failure; 5. History of obstructive sleep apnea (OSA), acute upper respiratory infection, asthma and other respiratory diseases.

Design outcomes

Primary

Measure	Time frame
Laryngeal mask insertion reaction;	—

Countries

China

Contacts

Public ContactYingshuai Qiao

He'nan Cancer Hospital

qiaoyingshuai@163.com+86 18539953837

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026